Varonis Files Merger Proxy; Stockholders to Vote Dec. 22 on $49.75 Cash Sale to Proofpoint
Varonis Systems filed a definitive merger proxy setting a December 22, 2026 special meeting where stockholders will vote on its $49.75-per-share cash acquisition by Proofpoint, a Thoma Bravo affiliate.
What happened
Varonis Systems, Inc. (Nasdaq: VRNS), a Miami-based data security software company, filed a definitive merger proxy statement (Form DEFM14A) with the SEC on November 16, 2026, and began mailing it to stockholders the same day.
The filing sets a virtual special meeting for December 22, 2026 at 10:30 a.m. Eastern Time, where stockholders will vote on adopting the Agreement and Plan of Merger dated October 15, 2026.
Under that agreement, Proofpoint, Inc. — described in the filing as an affiliate of private equity firm Thoma Bravo, L.P. — will acquire Varonis through a merger of its wholly owned subsidiary, Vail Merger Sub, Inc., into Varonis. Varonis would survive as a wholly owned subsidiary of Proofpoint.
Stockholders will receive $49.75 in cash per share if the deal closes. Varonis closed at $49.09 on the day the proxy was filed, up 0.31% from the prior close of $48.94, according to the price data.
The proxy notes that shareholders who properly exercise appraisal rights under Section 262 of Delaware law may instead seek a court determination of the fair value of their shares.
The vote and the board's position
Varonis' board formed a transaction committee to review and negotiate the deal with financial and legal advisors. The board then unanimously recommended, on the committee's unanimous recommendation, that stockholders vote "FOR" the merger agreement.
Approval requires the affirmative vote of a majority of the voting power outstanding as of the November 16 record date. The filing states plainly that a failure to vote, assuming a quorum is present, has the same effect as a vote against the merger.
Stockholders are also voting on a non-binding advisory proposal on merger-related compensation for Varonis' named executive officers, and on a proposal to adjourn the meeting if needed to solicit more votes or distribute amended materials. The board recommends "FOR" all three.
The filing does not explain why Thoma Bravo and Proofpoint are acquiring Varonis or why the $49.75 price was reached; that detail would sit in the board's reasons for the merger and the fairness opinion from Goldman Sachs, which are referenced in the table of contents but not included in the excerpt reviewed here.
What this means
A DEFM14A is the definitive version of a merger proxy statement. A company must file one when it asks shareholders to approve a transaction and needs their votes; the "DEF" prefix means the document is final and is being sent to holders, as opposed to the preliminary filings that come before it. It is not a report of an event that has already happened — it is the formal notice that a vote is scheduled.
The instrument at the center of this story is a cash merger. Varonis shares cease to trade once the deal closes, and holders are paid $49.75 per share in cash instead of receiving stock in the acquirer. That cash price is why the stock trades near it: at $49.09, shares sit roughly 66 cents below the deal price, a gap that reflects the time until closing and the risk the vote or regulatory approvals fail.
Proofpoint is itself a cybersecurity company, one that went private in 2021, and here it appears as the acquisition vehicle affiliated with Thoma Bravo. The structure is standard for private equity deals: a shell subsidiary (Vail Merger Sub) merges into the target, and the target's shares are cancelled for cash.
For Varonis shareholders, the vote is the consequential step. If a majority of shares outstanding approves the merger, and the remaining conditions — including regulatory approvals, which the proxy section headers list but do not detail in the excerpt — are satisfied, the merger closes and the shares are converted into the $49.75 payment. If the proposal fails, the merger agreement terminates under its terms. The filing does not forecast a closing date or discuss any expected regulatory review timeline in the portion reviewed.
Sources
- DEFM14A filed 2026-11-16
- Daily price history
Information summarized by AI from the sources listed above. May contain errors — informational only, not investment advice.